Clinical trials: Marburg Virus Disease (MVD)
Marburg Virus Disease (MVD)
A Study to Investigate the Safety, Reactogenicity, and Immunogenicity of a Preventative Vaccine for Marburg Virus (mRNA-1519) in Healthy Adult Participants
The main objective of this trial is to evaluate the safety, reactogenicity, and immunogenicity of mRNA-1519
- Trial name
- NCT07919210
- Testing
- mRNA-1519
- Where
- United Kingdom
- Volunteers
- 64 people, healthy volunteers welcome
- Sponsor
- ModernaTX, Inc.